Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

L1 GROUP LIMITED Share Issue/Capital Change 2017

Jun 25, 2017

65211_rns_2017-06-25_306f0548-e4ee-4d5b-bdf4-14d206b5e5ef.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Platinum Asset Management Limited (the Company )

ABN

13 050 064 287

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or
to be issued (if known) or
maximum number which may
be issued
3
Principal
terms
of
the
+securities
(e.g.
if
options,
exercise price and expiry date; if
partly
paid
+securities,
the
amount outstanding and due
dates
for
payment;
if
+convertible
securities,
the
conversion price and dates for
conversion)
Deferred Rights (not quoted) to receive an
equivalent number of the Company’s shares.
Upon exercise of the Deferred Rights,
employees will receive shares in the Company
that have been previously acquired on-market
by the Company’s Employee Share Trust and
held on behalf of employees.
1,034,448 Deferred Rights allocated under the
Platinum Asset Management Limited Deferred
Bonus Plan (Plan) that was approved by the
Company’s Nomination and Remuneration
Committee on 9 June 2017.
See Annexure A

4 Do the[+] securities rank equally No, the Deferred Rights do not rank equally in in all respects from the[+] issue all respects with the existing class of quoted securities. date with an existing[+] class of quoted[+] securities? Prior to the Deferred Rights being exercised, there is no entitlement to vote and receive If the additional[+] securities do dividends. not rank equally, please state:  the date from which they do After the Deferred Rights have vested and been  the extent to which they exercised, the employee will receive ordinary participate for the next shares (previously purchased on-market). dividend, (in the case of a These ordinary shares will rank equally with the trust, distribution) or existing class of quoted securities (including an entitlement to vote and receive dividends). interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration Nil 6 Purpose of the issue Issue of Deferred Rights under the (If issued as consideration for Plan in respect of the 2017 financial year. the acquisition of assets, clearly identify those assets) 6a Is the entity an[+] eligible entity No that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the[+] securities the subject of this Appendix 3B , and comply with section 6i 6b The date the security holder Not applicable resolution under rule 7.1A was passed 6c Number of[+] securities issued Not applicable without security holder approval under rule 7.1 6d Number of[+] securities issued Not applicable with security holder approval under rule 7.1A

  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

6e
Number of+securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)
6f
Number of+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which
valuation
of
consideration was released to
ASX Market Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
Not applicable
Not applicable

Not applicable
Not applicable
Not applicable

7 +Issue dates 23 June 2017 Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B.

Number +Class 8 Number and +class of all 586,678,900 Fully paid ordinary +securities quoted on ASX shares ( including the +securities in section 2 if applicable) Number +Class 9 Number and +class of all 1,626,026 Deferred Rights +securities not quoted on ASX allocated under the ( including the +securities in Plan. section 2 if applicable) We note that, on exercise of the Deferred Rights, any shares issued under the Plan will have been previously acquired on-market. Therefore, no new shares will be issued under the Plan. 10 Dividend policy (in the case of a Not applicable trust, distribution policy) on the increased capital (interests)

  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Part 2 - Pro rata issue

Items 11 to 33 are not applicable

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

  • (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Items 34 to 42 are not applicable.

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

    • Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 26/06/2017

(Company secretary)

Print name: .Joanne Jefferies.........................................

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Appendix 3B – Annexure A

Item 3 – Principal terms of the securities

Nature of Deferred
Rights
Each Deferred Right represents a right to receive one
(1) ordinary share in the capital of the Company,
subject to the terms and conditions of the Plan rules.
Prior to a Deferred Right being exercised an eligible
employee is not entitled to any voting rights or to
receive dividends.
The Company’s shares that will be allocated to each
eligible employee will be, prior to exercise, acquired (by
a separate employee share trust) on-market and not
through the issue of new shares.
Unvested Deferred Rights will lapse on cessation of
employment except if the board decides otherwise.
Determination of the
Number of Deferred
Rights
The number of Deferred Rights has been determined
by dividing an eligible employees’ Deferred Bonus
award by $4.64 being the volume weighted average
price (VWAP) of the Company’s shares based on the
end of day closing share price over the 7 trading days
prior to 20 June 2017 (Grant Date).
Grant Date 20 June 2017
Acceptance Date 23 June 2017
Vesting Date 20 June 2021
Exercise Expiry Date 20 June 2026
Vesting Conditions Continuous employment until the Vesting Date
Deferred Right Exercise
Price
Nil
Dividend Equivalent
Payment
The Deferred Rights also carry an entitlement to a
Dividend Equivalent Payment.
Upon the valid exercise of a Deferred Right, or deemed
exercise, of a Deferred Right, an eligible employee will
be entitled to receive an amount approximately equal to
the amount of dividends that would have been paid to
the eligible employee had they held the share from the
Grant Date to the date that the Deferred Rights are
exercised.
  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013